Skip to main content
. 2022 Aug 23;13:921306. doi: 10.3389/fgene.2022.921306

TABLE 2.

The clinicopathological features of circSMARCA5 in several human cancers.

Tumor types Clinicopathological features Ref
GC poor tumor differentiation, more lymph node metastasis, vascular invasion, high AJCC stage, poor OS and DFS Cai and Zuo, (2019)
GBM advanced histological grade, more blood vascular microvessel density, poor OS and PFS (Barbagallo et al., 2018; Barbagallo et al., 2019)
HCC poor tumor differentiation, high TNM stage, microvascular invasion, large tumor size and more tumor lesions (Yu et al., 2018; Zhang et al., 2018; Li ad Hu, 2019)
NSCLC large tumor size, more lymphatic metastasis and high TNM stage (Tong, 2020; Zhang et al., 2020)
ICC ECOG performance score, advanced TNM stage and abnormal CA199 status Lu, (2020)
MM high beta-2-microglobulin levels, poor complete response and short OS and PFS after effective chemotherapy Liu et al. (2019)
BCa larger tumor size, higher tumor stage, lymphatic metastasis and worse DFS and OS (Tan and Liang. 2019; Zhang X et al., 2021)

Abbreviations: GC: gastric cancer; GBM: glioblastoma; HCC: hepatocellular carcinoma; NSCLC: non-small -cell lung cancer; ICC: intrahepatic cholangiocarcinoma; MM: multiple myeloma; BCa: bladder cancer.